Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.contractpharma.com/contents/view_breaking-news/2024-06-24/ani-pharmaceuticals-to-acquire-alimera-sciences/9769
https://www.globenewswire.com/news-release/2024/06/04/2893463/12565/en/Alimera-Sciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/14/2881277/12565/en/Alimera-Sciences-Reports-First-Quarter-2024-Results.html
https://www.globenewswire.com/news-release/2024/05/07/2876686/12565/en/Alimera-Announces-Scientific-Data-Highlighting-YUTIQ-to-be-Presented-at-Upcoming-Association-for-Research-in-Vision-and-Ophthalmology-and-Retina-World-Congress-Conferences.html
https://www.globenewswire.com/news-release/2024/04/30/2872197/12565/en/Alimera-Sciences-to-Report-First-Quarter-2024-Financial-Results-on-May-14-2024-and-Provide-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/03/20/2849329/12565/en/Alimera-Sciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/03/19/2848492/12565/en/Alimera-Announces-First-Patient-Randomized-in-Radiation-Retinopathy-Trial-Being-Conducted-by-the-DRCR-Retina-Network.html
https://www.globenewswire.com//news-release/2024/03/07/2842155/12565/en/Alimera-Sciences-Reports-Fourth-Quarter-and-Full-Year-2023-Results.html
https://www.globenewswire.com//news-release/2024/02/29/2837925/12565/en/Alimera-Sciences-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-March-7-2024-and-Provide-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/02/08/2825962/12565/en/The-UK-National-Institute-for-Health-and-Care-Excellence-NICE-Issues-Final-Draft-Guidance-to-Provide-Patients-with-a-Natural-Lens-Phakic-Eye-Being-Treated-for-Chronic-Diabetic-Macu.html